Hopital de Bobigny
Bobigny, 93009, France
NCT Number: NCT00472160
Critically ill patients are predisposed to oxyhaemoglobin desaturation during intubation. For the intubation of hypoxemic patients, preoxygenation using non invasive ventilation (NIV) is more effective at reducing arterial oxyhaemoglobin desaturation than standard method.
Objectives: To find out whether NIV, as a preoxygenation method, is more effective at reducing the degree of organ dysfunction/failure than standard preoxygenation during the week following endotracheal intubation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Bobigny, 93009, France
During the inclusion period (at least 10 min and maximum 30 min), the patients ware a high FiO2 mask, driven by 10-15L/min oxygen and are randomly assigned to control or NIV group. Preoxygenation is then performed for a 3 minute period prior to a standardized rapid sequence intubation. For the control group, preoxygenation use a non-re-breather bag-valve mask driven by 15L/min oxygen. Patients allow to breath spontaneously with occasional assists (usual preoxygenation method). For the NIV group, pressure support mode is delivered by an ICU ventilator through a face mask adjusted to obtain an expired tidal volume of 7 to 10 mL/kg. The fraction of inspired oxygen (FiO2) was 100% and we used a PEEP level of 5 cmH2O.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non Invasive Ventilation
Time frame: the first week
Time frame: during the intubation
Time frame: during the 7 days after intubation
Time frame: during the stay in reanimation
Time frame: in reanimation
Assistance Publique - Hôpitaux de Paris
Other
Preoxygenation Using Noninvasive Ventilation Prior Intubation in Hypoxemic Patients
Acronym: PREOXY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05481515
Critical Illness, Disease Attributes
London, United Kingdom
View Trial DetailsNCT06374225
Burns, Critical Illness
Aurora, Colorado, United States
View Trial DetailsNCT03789396
Critical Illness, Disease Attributes
Aurora, Colorado, United States
View Trial DetailsNCT02666937
Critical Illness, Disease Attributes
Amsterdam, North Holland, Netherlands
View Trial Details